Seagen

Seagen is a biotechnology company that develops and commercializes monoclonal antibody-based therapies for the treatment of cancer. Read more

Clay Siegall's photo - Chairman & CEO of Seagen

Chairman & CEO

Clay Siegall

CEO Approval Rating

90/100

Founded:

1998

Status:

PublicIndependent CompanyNASDAQSEGN

SEAGEN TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

AbbVie is one of Seagen's top competitors. AbbVie was founded in 2013 in North Chicago, Illinois. Like Seagen, AbbVie also operates in the Pharmaceuticals industry. AbbVie generates $50.2B more revenue than Seagen.

Almac is a top competitor of Seagen. Almac was founded in 2002, and is headquartered in Craigavon, England. Almac operates in the Health Care Technology industry. Almac generates $858M more revenue vs. Seagen.

Ambrx is seen as one of Seagen's top competitors. Ambrx is headquartered in La Jolla, California, and was founded in 2003. Like Seagen, Ambrx also competes in the Pharmaceuticals field. Ambrx generates NaN% the revenue of Seagen.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Agensys a competitor of Seagen?

Seagen Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$4.5M

Seagen's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 2.1B. Over the last three quarters, Seagen's revenue has grown by 12.7%. Specifically, in Q1 2021's revenue was $ < 1M; in Q4 2020, it was $3.8M; in Q3 2020, it was $ < 1M.

Seagen Acquisitions

No recent acquisitions found related to Seagen

Seagen Funding History

Since Seagen was founded in 1998, it has participated in 2 rounds of funding. In total Seagen has raised $60.5M. Seagen's last funding round was on May 2009 for a total of $11.5M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
May 2009
$11.5M
-
IPO
Mar 2001
$49M
-

Since Seagen was founded in 1998, it has participated in 2 rounds of funding. In total Seagen has raised $60.5M. Seagen's last funding round was on May 2009 for a total of $11.5M

Seagen Investments

No recent investments found related to Seagen

Seagen News

June 3, 2021Benzinga

Updated Analysis Show Seagen's Tukysa Extended Median OS to Two Years with Benefits Maintained in Breast Cancer

Seagen Inc (NASDAQ: SGEN) has announced that improvements in overall survival (OS) and progression-fr... See more »
May 21, 2021Born2Invest

forty million in R&D and agreement with Esteve

The company Seagen, which works with improved antibodies that make the drugs more potent, has revenue... See more »
April 27, 2021The Business Journals: Seattle

Seagen makes lofty debut on list of world's most innovative pharma companies

"Success is achieved by discovering and developing meaningfully great medicines and getting those med... See more »
April 9, 2021MarketScreener

to Highlight Data from Novel Targeted Therapies at AACR

(marketscreener.com) -Data Showcase Depth of Oncology Pipeline Using Seagen's Innovative Technologies... See more »
April 7, 2021BioSpace

Seagen to Host Conference Call and Webcast Discussion of First Quarter 2021 Financial Results on April 29, 2021

Seagen Inc. (Nasdaq: SGEN) today announced that it will report its first quarter 2021 financial resul... See more »

Seagen Press Releases

April 29, 2021Business Wire

Seagen to Showcase Data from Growing Oncology Portfolio During Virtual Scientific Program of the 2021 ASCO Annual Meeting

BOTHELL, Wash.--(BUSINESS WIRE)-- #ASCO2021--Seagen to Showcase Data from Growing Oncology Portfolio ... See more »
February 24, 2021Business Wire

Seagen to Present at the Cowen 41st Annual Healthcare Conference

BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq: SGEN) today announced that management will part... See more »
January 7, 2021Business Wire

Seagen to Host Conference Call and Webcast Discussion of Fourth Quarter and Full Year 2020 Financial Results on February 11, 2021

BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq: SGEN) today announced that it will report its f... See more »

Social Media

Seagen Headquarters

21717 30th Drive S.E Building 3

Bothell, Washington98021

1-425-527-4000

Driving Directions »

Trending Companies

Seagen Summary

ABOUT

Overview

Seagen is a biotechnology company that develops and commercializes monoclonal antibody-based therapies for the treatment of cancer. Seagen was founded in 1998. Seagen's headquarters is located in Bothell, Washington, USA 98021. It has raised 60.5M in ...

CEO

Seagen's Chairman & CEO, Clay Siegall, currently has an approval rating of 90%. Seagen's primary competitors are AbbVie, Almac & Ambrx.

Website

seagen.com

Frequently Asked Questions about Seagen

  1. When was Seagen founded?

    Seagen was founded in 1998
  2. Who is Seagen's CEO?

    Seagen's CEO is Clay Siegall
  3. How much revenue does Seagen generate?

    Seagen generates $4.5M in revenue
  4. How much funding does Seagen have?

    Seagen has historically raised $60.5M in funding
  1. Where is Seagen's headquarters?

    Seagen's headquarters is in Bothell Washington, USA
  2. How many employees does Seagen have?

    Seagen has 2,092 employees
  3. What sector does Seagen operate in?

    Seagen is in Pharmaceuticals
  4. Who are Seagen's competitors?

    Seagen's top competitors are AbbVie, Almac, Ambrx